160 related articles for article (PubMed ID: 35142454)
1. Growth hormone replacement therapy in pediatric brain tumor survivors.
Sodero G; Agresti P; Triarico S; Romano A; Mastrangelo S; Attinà G; Maurizi P; Cipolla C; Ruggiero A
Minerva Pediatr (Torino); 2022 Jun; 74(3):340-348. PubMed ID: 35142454
[TBL] [Abstract][Full Text] [Related]
2. Sex Differences in Long-Term Safety and Tolerability of GH Replacement Therapy in GH Deficient Adults.
Slagboom TNA; van Bunderen CC; van der Lely AJ; Drent ML
J Clin Endocrinol Metab; 2023 Jun; 108(7):e415-e424. PubMed ID: 36652411
[TBL] [Abstract][Full Text] [Related]
3. Safety of Growth Hormone Replacement Therapy in Childhood-Onset Craniopharyngioma: A Systematic Review and Cohort Study.
van Schaik J; Kormelink E; Kabak E; van Dalen EC; Schouten-van Meeteren AYN; de Vos-Kerkhof E; Bakker B; Fiocco M; Hoving EW; Tissing WJE; van Santen HM
Neuroendocrinology; 2023; 113(10):987-1007. PubMed ID: 37231961
[TBL] [Abstract][Full Text] [Related]
4. Long-term safety of growth hormone replacement after CNS irradiation.
Mackenzie S; Craven T; Gattamaneni HR; Swindell R; Shalet SM; Brabant G
J Clin Endocrinol Metab; 2011 Sep; 96(9):2756-61. PubMed ID: 21715535
[TBL] [Abstract][Full Text] [Related]
5. GH and Childhood-onset Craniopharyngioma: When to Initiate GH Replacement Therapy?
Nguyen Quoc A; Beccaria K; González Briceño L; Pinto G; Samara-Boustani D; Stoupa A; Beltrand J; Besançon A; Thalassinos C; Puget S; Blauwblomme T; Alapetite C; Bolle S; Doz F; Grill J; Dufour C; Bourdeaut F; Abbou S; Guerrini-Rousseau L; Leruste A; Brabant S; Cavadias I; Viaud M; Boddaert N; Polak M; Kariyawasam D
J Clin Endocrinol Metab; 2023 Jul; 108(8):1929-1936. PubMed ID: 36794424
[TBL] [Abstract][Full Text] [Related]
6. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.
Olsson DS; Buchfelder M; Wiendieck K; Kremenevskaja N; Bengtsson BÅ; Jakobsson KE; Jarfelt M; Johannsson G; Nilsson AG
Eur J Endocrinol; 2012 Jun; 166(6):1061-8. PubMed ID: 22457235
[TBL] [Abstract][Full Text] [Related]
7. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement.
Gleeson HK; Stoeter R; Ogilvy-Stuart AL; Gattamaneni HR; Brennan BM; Shalet SM
J Clin Endocrinol Metab; 2003 Aug; 88(8):3682-9. PubMed ID: 12915655
[TBL] [Abstract][Full Text] [Related]
8. Provincial disparities of growth hormone coverage for young adult survivors of paediatric brain tumours across Canada.
Hasan H; Howard F; Morgan SG; Metzger DL; Lo AC; Goddard K; Gill S; Johnson M
Healthc Policy; 2014 Feb; 9(3):80-96. PubMed ID: 24726076
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone therapy and risk of recurrence/progression in intracranial tumors: a meta-analysis.
Shen L; Sun CM; Li XT; Liu CJ; Zhou YX
Neurol Sci; 2015 Oct; 36(10):1859-67. PubMed ID: 26048536
[TBL] [Abstract][Full Text] [Related]
10. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
11. GH deficiency in adult survivors of childhood cancer.
Felicetti F; Fortunati N; Arvat E; Brignardello E
Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):795-804. PubMed ID: 27974192
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control.
Packer RJ; Boyett JM; Janss AJ; Stavrou T; Kun L; Wisoff J; Russo C; Geyer R; Phillips P; Kieran M; Greenberg M; Goldman S; Hyder D; Heideman R; Jones-Wallace D; August GP; Smith SH; Moshang T
J Clin Oncol; 2001 Jan; 19(2):480-7. PubMed ID: 11208842
[TBL] [Abstract][Full Text] [Related]
13. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.
Olsson DS; Buchfelder M; Schlaffer S; Bengtsson BA; Jakobsson KE; Johannsson G; Nilsson AG
Eur J Endocrinol; 2009 Nov; 161(5):663-9. PubMed ID: 19734242
[TBL] [Abstract][Full Text] [Related]
14. Response to GH Treatment After Radiation Therapy Depends on Location of Irradiation.
Rose SR; Carlsson M; Grimberg A; Aydin F; Albanese A; Hokken-Koelega ACS; Camacho-Hubner C
J Clin Endocrinol Metab; 2020 Oct; 105(10):e3730-41. PubMed ID: 32706856
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone treatment and risk of recurrence or progression of brain tumors in children: a review.
Bogarin R; Steinbok P
Childs Nerv Syst; 2009 Mar; 25(3):273-9. PubMed ID: 19142625
[TBL] [Abstract][Full Text] [Related]
16. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy.
Golgeli A; Tanriverdi F; Suer C; Gokce C; Ozesmi C; Bayram F; Kelestimur F
Eur J Endocrinol; 2004 Feb; 150(2):153-9. PubMed ID: 14763913
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety of growth hormone replacement therapy in survivors of cancer and tumors of the pituitary region.
Bolier M; van der Lelij AJ; Janssens GO; van den Heuvel-Eibrink MM; Neggers SJCMM
Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37043373
[TBL] [Abstract][Full Text] [Related]
18. The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy.
Mukherjee A; Tolhurst-Cleaver S; Ryder WD; Smethurst L; Shalet SM
J Clin Endocrinol Metab; 2005 Mar; 90(3):1542-9. PubMed ID: 15613427
[TBL] [Abstract][Full Text] [Related]
19. Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood.
Biscotto IP; Costa Hong VA; Batista RL; Mendonca BB; Arnhold IJP; Bortolotto LA; Carvalho LRS
Pituitary; 2021 Apr; 24(2):216-228. PubMed ID: 33098037
[TBL] [Abstract][Full Text] [Related]
20. GH deficiency in cancer survivors in the transition age: diagnosis and therapy.
Sbardella E; Crocco M; Feola T; Papa F; Puliani G; Gianfrilli D; Isidori AM; Grossman AB
Pituitary; 2020 Aug; 23(4):432-456. PubMed ID: 32488760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
